GlassScriptPhysician profile
Behrouz Farahmandpour
NPI 1447246756
$29,833.25
in general payments reported to CMS, 2019-2025
52 companies · $4,893 in 2025
The $4,893 reported for 2025 was more than what 99% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,208 · 2020: $1,969 · 2021: $4,294 · 2022: $4,873 · 2023: $6,048 · 2024: $4,548 · 2025: $4,893.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $15K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $15,488.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $5,466.09 | 2019-2025 | Farxiga, Breztri, Airsupra |
| Glaxosmithkline, LLC. | $4,361.26 | 2019-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Mannkind Corporation | $2,229.41 | 2021-2025 | Afrezza, V-Go |
| Amgen INC. | $2,027.40 | 2019-2025 | Repatha, Uplizna, Otezla |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,960.00 | 2019-2025 | Jardiance, Synjardy, Spiriva Respimat |
| Lilly USA, LLC | $1,687.75 | 2019-2025 | Jardiance, Zepbound, Mounjaro |
| Abbvie INC. | $1,492.00 | 2021-2025 | |
| Novo Nordisk INC | $1,260.57 | 2019-2025 | Ozempic, Wegovy, Rybelsus |
| Philips North America LLC | $1,128.45 | 2019-2025 | Vest Therapy Und, (Ak6) Vest Therapy |
| Abbott Laboratories | $1,089.00 | 2021-2024 | Freestyle Libre 3, Optis, Freestyle Libre 2 |
| Otsuka America Pharmaceutical, INC. | $686.51 | 2023-2025 | Rexulti |
| Janssen Pharmaceuticals, INC | $655.96 | 2019-2025 | Xarelto, Spravato |
| Pfizer INC. | $539.06 | 2020-2025 | |
| Medtronic, INC. | $465.75 | 2023-2024 | Onyx Frontier, Cd Horizon Spinal System, Linq II |
| Merck Sharp & Dohme LLC | $443.56 | 2019-2023 | Verquvo, Belsomra, Steglatro |
Show all 52 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $349.90 | 2023-2024 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Regeneron Healthcare Solutions, INC. | $309.47 | 2023-2025 | Dupixent |
| Biohaven Pharmaceuticals, INC. | $272.20 | 2021 | |
| Exact Sciences Corporation | $271.02 | 2023-2025 | Cologuard Collection Kit |
| Teva Pharmaceuticals USA, INC. | $244.55 | 2019-2020 | |
| Intuity Medical INC | $233.08 | 2022-2023 | Pogo Automatic Blood Glucose Monitoring System |
| Paratek Pharmaceuticals, INC. | $224.05 | 2021-2024 | Nuzyra |
| Intra-Sana Laboratories | $216.67 | 2023 | Reltone 400 Mg, Glycate, Reltone 200 Mg |
| Biohaven Pharmaceutical Holding Company LTD. | $200.64 | 2022 | |
| Renalytix Ai, INC. | $172.98 | 2025 | Kidneyintelx Blood Collection Convenience Kit |
| Allergan, INC. | $167.74 | 2019-2020 | |
| Viiv Healthcare Company | $142.23 | 2023-2024 | Apretude |
| Alexion Pharmaceuticals, INC. | $135.46 | 2024 | Strensiq |
| Novartis Pharmaceuticals Corporation | $126.45 | 2020-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $122.19 | 2022 | |
| Sk Life Science, INC. | $118.63 | 2023 | Xcopri |
| Electromed, INC. | $110.65 | 2022-2025 | Smartvest |
| Axsome Therapeutics, INC. | $110.36 | 2025 | Symbravo |
| Genzyme Corporation | $106.16 | 2024 | |
| Shield Therapeutics INC | $103.61 | 2023-2025 | Accrufer |
| Echosens North America, INC. | $94.32 | 2025 | Fibroscan |
| Ardelyx, INC. | $84.14 | 2024-2025 | Ibsrela |
| Verona Pharma, INC. | $63.78 | 2025 | Ohtuvayre |
| Amarin Pharma, INC. | $55.86 | 2020-2022 | |
| Boston Scientific Corporation | $44.61 | 2023-2024 | Varithena Administration Pack |
| Insulet Corporation | $39.91 | 2023-2024 | Omnipod |
| Lundbeck LLC | $33.34 | 2022-2024 | Rexulti |
| Tactile Systems Technology INC | $25.23 | 2025 | Nimbl, Flexitouch Plus |
| Dexcom, INC. | $24.54 | 2024 | Dexcom G6 Transmitter |
| Edwards Lifesciences Corporation | $21.71 | 2021 | |
| Esperion Therapeutics, INC. | $19.93 | 2025 | Nexletol |
| Atricure, INC. | $19.13 | 2023 | |
| Idorsia Pharmaceuticals US INC | $18.75 | 2022 | |
| Corcept Therapeutics | $15.38 | 2025 | Korlym |
| Seqirus USA INC | $14.94 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $14.15 | 2021 | |
| Linus Health, INC. | $12.72 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Behrouz Farahmandpour listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.